Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Dr. Reddy’s announced the launch of Carboprost Tromethamine Injection USP Single-dose Vial, a therapeutic equivalent generic version of Hemabate®, 250 mcg/mL, approved by the FDA.
read more
Fresenius Kabi is voluntarily recalling two lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill in 100mL vials, to the user level due to the potential for glass particulate.
read more
Nosopharm and Evotec announced their partnership aimed at advancing NOSO-502, to the clinical stage, as well as developing a second-generation Odilorhabdin drug candidate.
read more
The FDA has issued warning letters to three repackers of API for significant violations of current good manufacturing practice (CGMP) requirements.
read more
Pii announced the expansion of its commercial team with the additions of Wayne Ideus, Wayne Grellner and Ryan McFarlane.
read more
Abveris and Harbour Antibodies H2L2 BV announced a partnership to offer fully-human antibody discovery service that combines Abveris’ antibody discovery services with the Harbour H2L2 human transgenic mouse platform.
read more
Cambrex has announced three senior appointments to further support the Contract development and Manufacturing Organization company.
read more
Cobra Biologics and Symbiosis Pharmaceutical Services announced the successful completion of their collaboration to develop synergistic and world leading capabilities.
read more
Cytovance® Biologics announced the appointment of Jesse McCool, Ph.D. as Chief Technology Officer.
read more
Regis Technologies has announced a new capability of Solid State Chemistry.
read more
Catalent’s Paragon Gene Therapy will assume the leases to two Novavax product development and manufacturing facilities.
read more
Lannett Company has entered into a three-year agreement with Elite Pharmaceuticals to be the exclusive U.S. distributor of a Dantrolene Capsules 25 mg, 50 mg and 100 mg.
read more
Just Biotherapeutics announced they have entered into an agreement with Teva for the design and development of a high productivity (HP) biomanufacturing process.
read more
Q2 Solutions conducted a sample tracking proof-of-concept (POC) using distributed ledger technology (DLT, aka blockchain) in partnership with HSBlox.
read more
Rafael Pharmaceuticals has entered into an out-licensing agreement with Ono Pharmaceutical.
read more